Table 2. Clinical Characteristics of Study Groups .
| Group | ||||
| Characteristics | T1DM | Autoantibody positive T2DM patients | Autoantibody negative T2DM patients | Controls |
| n | 39 | 34 | 40 | 40 |
| M/F (%) | 20(51.28%)/19(48.72%) | 13(38.2%)/21(61.8%) | 16(40%)/24(60%) | 22(55%)/18(45%) |
| Age (SD) y | 15.43(5.16) | 53.41 (8.80) | 51.02 (8.61) | 42.7(15.4) |
| BMI (SD) | Not determined | 29.10(4.84) | 30.63(3.88) | 26.16(5.01) |
| Hypertension (%) | Not determined | 19(55.9) | 25(62.5) | 0.0(0.0) |
| Family history of diabetes (%) | 18(46.15%) | 22(64.7) | 32(80%) | 0.0(0.0) |
| Insulin dependency (%) | 39(100) | 10(29.4) | 13(32.5) | 0.0(0.0) |
| Dislipidemia (%) | Not determined | 15(44.1) | 16(40) | 0.0(0.0) |
| Autoimmune diseases history | 1(2.56) | 6(17.6) | 7(17.5) | 0.0(0.0) |
n: number, M: Male, F: Female, SD: Standard Deviation, y: year, BMI: Body Mass Index